14 insiders reported 59 Form 4 transactions for Harmony Biosciences Holdings, Inc. (HRMY) over the past 18 months (most recent 2026-09-18). Recent activity: Budur Kumar (CHIEF MEDICAL OFFICER) Buy 900 shares, Budur Kumar (CHIEF MEDICAL OFFICER) Buy 900 shares, Budur Kumar (CHIEF MEDICAL OFFICER) Sell 1,800 shares, Budur Kumar (CHIEF MEDICAL OFFICER) Buy 400 shares, Budur Kumar (CHIEF MEDICAL OFFICER) Buy 400 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 900 | $27,621 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 900 | $27,243 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 1,800 | $77,426 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 400 | $12,276 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 400 | $12,108 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 800 | $34,400 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 10,406 | $319,360 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 25,446 | $770,250 |
| 2026-09-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 35,852 | $1.5M |
| 2026-09-09 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 12,200 | $374,418 |
| 2026-09-09 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 4,500 | $190,114 |
| 2026-09-09 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 1,000 | $42,795 |
| 2026-09-09 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 5,500 | $230,911 |
| 2026-09-09 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 10,754 | $325,524 |
| 2026-09-09 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 22,954 | $989,350 |
| 2026-05-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 18,750 | $0 |
| 2026-05-18 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 8,882 | $282,714 |
| 2026-04-09 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Buy | 7,500 | $0 |
| 2026-04-09 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Sell | 3,173 | $87,638 |
| 2026-01-28 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 3,746 | $139,164 |
| 2026-01-26 | Serafin Andrew | CHIEF STRATEGY OFFICER | Buy | 2,500 | $0 |
| 2026-01-26 | Serafin Andrew | CHIEF STRATEGY OFFICER | Sell | 1,116 | $41,091 |
| 2026-01-26 | Serafin Andrew | CHIEF STRATEGY OFFICER | Buy | 2,600 | $0 |
| 2026-01-26 | Serafin Andrew | CHIEF STRATEGY OFFICER | Sell | 1,126 | $41,459 |
| 2026-01-26 | Budur Kumar | CHIEF MEDICAL OFFICER | Buy | 2,188 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18